Advanced Research of Non-Coding RNAs in Health and Disease
This special issue belongs to the section "Molecular and Translational Medicine".
Special Issue Information
Dear Colleagues,
Non-coding RNAs (ncRNAs), are transcripts encoded by the genome that are largely not translated into proteins. They play essential roles in regulating gene expression and cellular signaling pathways, and alterations in their expression levels are associated with numerous diseases, including cancer.
Abundant and functionally important classes of ncRNAs include transfer RNAs (tRNAs), ribosomal RNAs (rRNAs), and several small RNAs such as microRNAs (miRNAs), small nucleolar RNAs (snoRNAs), PIWI-interacting RNAs (piRNAs), small nuclear RNAs (snRNAs), extracellular RNAs (exRNAs), small Cajal body-specific RNAs (scaRNAs), circular RNAs (circRNAs) as well as long non-coding RNAs (lncRNAs).
The presence of ncRNAs in the cytoplasm, nucleus, and extracellular space, where they can act as signaling molecules, adds another layer of regulatory complexity, as ncRNAs may have distinct targets and functions depending on their cellular localization.
The aim of this Special Issue is to collect original research articles, reviews and commentaries focused on the recent advances in the field of ncRNAs in both health and disease. A deeper understanding of the complex regulatory networks established by ncRNAs may ultimately provide a rich source of novel therapeutic targets.
Dr. Celestino Sardu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- miRNA
- cancer
- disease
- therapy
- biomarker
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

